Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018–2019 Influenza Season in the United States

Documenti analoghi

• Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-derived Quadrivalent Influenza Vaccines in Preventing Influenza-like Illness in 2017–2018
  di: Boikos, Constantina, et al.
  Pubblicazione: (2020)
• Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine in Individuals at High Risk of Influenza Complications in the 2018–2019 United States Influenza Season
  di: Boikos, Constantina, et al.
  Pubblicazione: (2021)
• Quadrivalent cell culture influenza virus vaccine. Comparison to egg-derived vaccine
  di: Pérez-Rubio, Alberto, et al.
  Pubblicazione: (2020)
• LB-2. Relative Effectiveness of aIIV3 versus IIV4 and HD-IIV3 In Preventing Influenza-Related Medical Encounters in Adults ≥65 Years of Age at High Risk for Influenza Complications During the U.S. 2017–2018 and 2018–2019 Influenza Seasons
  di: Fischer, Lauren, et al.
  Pubblicazione: (2020)
• Influenza burden averted with a cell-based quadrivalent seasonal influenza vaccine compared with egg-based quadrivalent seasonal influenza vaccine
  di: Ian McGovern, et al.
  Pubblicazione: (2024-12-01)